Synthetic, low molecular thrombin inhibitors. A new concept of anticoagulants?
D000578:Amidines / Q000494:pharmacology; D000925:Anticoagulants; D001555:Benzene Derivatives / Q000494:pharmacology; D001560:Benzidines / Q000494:pharmacology; D001667:Binding, Competitive; D002908:Chronic Disease; D004211:Disseminated Intravascular Coagulation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008970:Molecular Weight; D009943:Organophosphorus Compounds / Q000494:pharmacology; D011517:Prothrombin Time; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000037:antagonists & inhibitors*; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology
D000578:Amidines; D000925:Anticoagulants; D001555:Benzene Derivatives; D001560:Benzidines; D004791:Enzyme Inhibitors; D009943:Organophosphorus Compounds; D014106:Tosylarginine Methyl Ester; D013917:Thrombin